{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:52:20Z","timestamp":1791931940680,"version":"4.3.4"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>A scoping review was conducted to systematically assess the current evidence and emerging applications of regenerative medicine in the treatment of End Stage Renal Disease (ERSD), aiming to map existing knowledge and identify key research gaps. ESRD represents a major global health burden, and despite being managed primarily through dialysis and kidney transplantation, both approaches are limited by morbidity, mortality, and organ donor shortages. Regenerative medicine emerged as a promising alternative, leveraging stem cells technologies and tissue engineering to develop functional renal tissues with the potential to restore or replace damaged kidney structures. Our review protocol was developed in accordance with the PRISMA-ScR guidelines and was prospectively registered on Figshare. Inclusion criteria comprised peer-reviewed articles published between 2004 and 2024, focusing on bioengineering strategies relevant to kidney regeneration and ESRD, with no restrictions on language or geographic origin. Editorials, letters, and non\u2013peer-reviewed sources were excluded. A comprehensive literature search was performed in Medline, Scopus, and Web of Science using pre-defined search terms. Screening and selection were conducted independently by four reviewers working in pairs selected with discrepancies resolved through consensus. A standardized data extraction form was iteratively developed and piloted to collect relevant information on study characteristics and experimental models. Of the 5,869 records initially identified, 111 studies met the inclusion criteria. The findings underscore the therapeutic potential of regenerative medicine in ESRD, with kidney organoids and organ-on-a-chip platforms representing two of the most advanced and translationally relevant approaches currently under investigation. These technologies are increasingly recognized not only for their role in disease modeling and drug screening, but also as potential precursors to fully bioengineered renal replacement therapies.<\/jats:p>","DOI":"10.3389\/fendo.2025.1549744","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T10:03:49Z","timestamp":1752833029000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Preclinical approaches in regenerative medicine for treating end-stage renal disease: a scoping review"],"prefix":"10.3389","volume":"16","author":[{"given":"Andrea","family":"Vigezzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Brani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Dalla Gasperina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Azzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Giaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Inversini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pettinato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Massaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Carcano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ietto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreina","family":"Baj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Annals of Internal Medicine","volume":"169","author":"Tricco","year":"2018","journal-title":"Am Coll Physicians;"},{"key":"B3","article-title":"Kidney bioengineering for transplantation","volume-title":"Transplantation","author":"Ibi","year":"2023"},{"key":"B4","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(02)08028-5","article-title":"Immunisations in solid-organ transplant recipients","volume-title":"Lancet","author":"Stark","year":"2002"},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.1080\/14712598.2020.1709439","article-title":"Bioengineering strategies for nephrologists: kidney was not built in a day","volume-title":"Expert opinion on biological therapy","author":"Peired","year":"2020"},{"key":"B6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-bioeng-071910-124743","article-title":"Whole-organ tissue engineering: Decellularization and recellularization of three-dimensional matrix scaffolds","volume":"13","author":"Badylak","year":"2011","journal-title":"Annu Rev BioMed Eng"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.953408","article-title":"Approaches to kidney replacement therapies\u2014opportunities and challenges","volume":"10","author":"Huang","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nature15695","article-title":"Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis","volume":"526","author":"Takasato","year":"2015","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41563-019-0287-6","article-title":"Fine tuning the extracellular environment accelerates the derivation of kidney organoids from human pluripotent stem cells","volume":"18","author":"Garreta","year":"2019","journal-title":"Nat Mater"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3392","article-title":"Nephron organoids derived from human pluripotent stem cells model kidney development and injury","volume":"33","author":"Morizane","year":"2015","journal-title":"Nat Biotechnol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.devcel.2018.05.010","article-title":"Progressive recruitment of mesenchymal progenitors reveals a time-dependent process of cell fate acquisition in mouse and human nephrogenesis","volume":"45","author":"Lindstr\u00f6m","year":"2018","journal-title":"Dev Cell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00726-9","article-title":"Portable, wearable and implantable artificial kidney systems: needs, opportunities and challenges","volume":"19","author":"Ramada","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B13","first-page":"29","article-title":"Engraftment of kidney organoids in vivo","volume-title":"Current transplantation reports","author":"Freedman","year":"2023"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1177\/02676591221140767","article-title":"Ethics, virtues and xenotransplantation","volume":"39","author":"George","year":"2024","journal-title":"Perfusion (United Kingdom)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000004098","article-title":"Normothermic ex vivo kidney perfusion for human kidney transplantation: first north american results","volume":"106","author":"Mazilescu","year":"2022","journal-title":"Transplantation"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00573.x","article-title":"Administered mesenchymal stem cells enhance recovery from ischemia\/reperfusion-induced acute renal failure in rats","volume":"68","author":"Lange","year":"2005","journal-title":"Kidney Int"},{"key":"B17","volume-title":"figshare","year":"2024"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16100","article-title":"Novel delivery of cellular therapy to reduce ischemia reperfusion injury in kidney transplantation","volume":"21","author":"Thompson","year":"2021","journal-title":"Am J Transplantation"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16473","article-title":"Mesenchymal stromal cell treatment of donor kidneys during ex vivo normothermic machine perfusion: A porcine renal autotransplantation study","volume":"21","author":"Lohmann","year":"2021","journal-title":"Am J Transplantation"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2015.993376","article-title":"Prospect for kidney bioengineering: Shortcomings of the status quo","volume":"15","author":"Peloso","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"B21","first-page":"199","article-title":"3D bioprinting in tissue engineering and regenerative medicine","volume-title":"Cell and tissue banking","author":"Gupta","year":"2022"},{"key":"B22","first-page":"8","article-title":"Organ-on-chip technology: Opportunities and challenges","volume-title":"Biotechnology notes","author":"Srivastava","year":"2024"},{"key":"B23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41586-023-06594-4","article-title":"Design and testing of a humanized porcine donor for xenotransplantation","volume":"622","author":"Anand","year":"2023","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.17164","article-title":"De novo SIX2 activation in human kidneys treated with neonatal kidney stem\/progenitor cells","volume":"22","author":"Arcolino","year":"2022","journal-title":"Am J Transplantation"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2019.06.075","article-title":"Delayed transplantation of autologous mitochondria for cardioprotection in a porcine model","volume":"109","author":"Blitzer","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1016\/j.cell.2021.03.020","article-title":"Chimeric contribution of human extended pluripotent stem cells to monkey embryos ex vivo","volume":"184","author":"Tan","year":"2021","journal-title":"Cell"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110933","article-title":"Generation of functional chimeric kidney containing exogenous progenitor-derived stroma and nephron via a conditional empty niche","volume":"39","author":"Saito","year":"2022","journal-title":"Cell Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002455","article-title":"Potentiating renal regeneration using mesenchymal stem cells","volume":"103","author":"Brasile","year":"2019","journal-title":"Transplantation"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2018.01.008","article-title":"Generation of functioning nephrons by implanting human pluripotent stem cell-derived kidney progenitors","volume":"10","author":"Bantounas","year":"2018","journal-title":"Stem Cell Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2014.182","article-title":"The generation of kidney organoids by differentiation of human pluripotent cells to ureteric bud progenitor-like cells","volume":"9","author":"Xia","year":"2014","journal-title":"Nat Protoc"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/srep43502","article-title":"Experimental evaluation of kidney regeneration by organ scaffold recellularization","volume":"7","author":"Remuzzi","year":"2017","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001343","article-title":"Continuous normothermic ex vivo kidney perfusion improves graft function in donation after circulatory death pig kidney transplantation","volume":"101","author":"Kaths","year":"2017","journal-title":"Transplantation"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1549744\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T10:03:51Z","timestamp":1752833031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1549744\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":32,"alternative-id":["10.3389\/fendo.2025.1549744"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1549744","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"article-number":"1549744"}}